BIIO (Bionovate Technologies) Notes Receivable: $0.00 Mil (As of Sep. 2021)


What is Bionovate Technologies Notes Receivable?

Bionovate Technologies BIIO Notes Receivable is $0.00 Mil as of Sep. 2021.

Bionovate Technologies's Notes Receivable for the quarter that ended in Sep. 2021 was $0.00 Mil.

Bionovate Technologies Notes Receivable Related Terms

Bionovate Technologies Notes Receivable Historical Data

* Premium members only.

The historical data trend for Bionovate Technologies's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bionovate Technologies Notes Receivable Chart

Bionovate Technologies Annual Data
Trend Jun13 Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21
Notes Receivable
Get a 7-Day Free Trial Premium Member Only 0.00 0.00 0.00 0.00 0.00

Bionovate Technologies Quarterly Data
Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21
Notes Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Bionovate Technologies Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.

Frequently Asked Questions Learn more about Notes Receivable →
What does a Notes Receivable of $0.00 Mil mean?
Bionovate Technologies (BIIO) has a Notes Receivable of $0.00 Mil as of Sep. 2021. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Bionovate Technologies and its competitors.
Is Bionovate Technologies' Notes Receivable too high?
Bionovate Technologies' current Notes Receivable is $0.00 Mil.
How does Bionovate Technologies' Notes Receivable compare to ABT and MDT?
Bionovate Technologies' Notes Receivable of $0.00 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Notes Receivable for a Medical Devices & Instruments company?
A good Notes Receivable depends on the Medical Devices & Instruments industry context. However, Notes Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Notes Receivable mean?
A high Notes Receivable can signal that a stock is expensive relative to its fundamentals. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Bionovate Technologies and its competitors. Bionovate Technologies's current Notes Receivable is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bionovate Technologies stock overvalued right now?
Bionovate Technologies (BIIO) has a current Notes Receivable of $0.00 Mil. The current Notes Receivable is $0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Notes Receivable calculated?
Notes Receivable is calculated from a company's financial statements. For Bionovate Technologies (BIIO), the current Notes Receivable is $0.00 Mil as of Sep. 2021. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Bionovate Technologies Business Description

Address 950 W Bannock Street, Boise, ID, USA, 83702
Bionovate Technologies Corp operates in the medical devices and diagnostics sector with a focus on mobile technologies.